Press Archives - Sanguine

Sanguine Biosciences Announces the Launch of LeukoCert™ GMP Leukopaks

By mbalanadu | November 4, 2024 |

<img width="1024" height="512" src="https://sanguinebio.com/wp-content/uploads/2024/11/Leukocert-PR-1-1024x512.jpg" class="attachment-large size-large wp-post-image" alt="" aria-label="Sanguine Biosciences Announces the Launch of LeukoCert™ GMP Leukopaks" decoding="async" fetchpriority="high" srcset="https://sanguinebio.com/wp-content/uploads/2024/11/Leukocert-PR-1-1024x512.jpg 1024w, https://sanguinebio.com/wp-content/uploads/2024/11/Leukocert-PR-1-300x150.jpg 300w, https://sanguinebio.com/wp-content/uploads/2024/11/Leukocert-PR-1-768x384.jpg 768w, https://sanguinebio.com/wp-content/uploads/2024/11/Leukocert-PR-1-1536x768.jpg 1536w, https://sanguinebio.com/wp-content/uploads/2024/11/Leukocert-PR-1-2048x1024.jpg 2048w, https://sanguinebio.com/wp-content/uploads/2024/11/Leukocert-PR-1-1140x570.jpg 1140w, https://sanguinebio.com/wp-content/uploads/2024/11/Leukocert-PR-1-740x370.jpg 740w" sizes="(max-width: 1024px) 100vw, 1024px" />

Sanguine Biosciences is pleased to announce the launch of LeukoCert™, GMP-grade leukopaks designed for cell therapy manufacturing.

Sanguine Biosciences Achieves Key ISO Certifications for Quality, Security, and Privacy

By mbalanadu | September 20, 2024 |

<img width="1024" height="512" src="https://sanguinebio.com/wp-content/uploads/2024/09/collage-LN-1-1024x512.png" class="attachment-large size-large wp-post-image" alt="" aria-label="Sanguine Biosciences Achieves Key ISO Certifications for Quality, Security, and Privacy" decoding="async" srcset="https://sanguinebio.com/wp-content/uploads/2024/09/collage-LN-1-1024x512.png 1024w, https://sanguinebio.com/wp-content/uploads/2024/09/collage-LN-1-300x150.png 300w, https://sanguinebio.com/wp-content/uploads/2024/09/collage-LN-1-768x384.png 768w, https://sanguinebio.com/wp-content/uploads/2024/09/collage-LN-1-1536x768.png 1536w, https://sanguinebio.com/wp-content/uploads/2024/09/collage-LN-1-2048x1024.png 2048w, https://sanguinebio.com/wp-content/uploads/2024/09/collage-LN-1-1140x570.png 1140w, https://sanguinebio.com/wp-content/uploads/2024/09/collage-LN-1-740x370.png 740w" sizes="(max-width: 1024px) 100vw, 1024px" />

Sanguine Biosciences Prioritizes Excellence, Information Security, and Privacy with ISO Certifications.

Sanguine Biosciences Using VERIF.i® on Scientist.com

By mbalanadu | May 6, 2024 |

Sanguine Verif.i

<img width="741" height="337" src="https://sanguinebio.com/wp-content/uploads/2024/04/Sanguine-Verif.i-Option-3.jpg" class="attachment-large size-large wp-post-image" alt="Sanguine Verif.i" aria-label="Sanguine Biosciences Using VERIF.i® on Scientist.com" decoding="async" srcset="https://sanguinebio.com/wp-content/uploads/2024/04/Sanguine-Verif.i-Option-3.jpg 741w, https://sanguinebio.com/wp-content/uploads/2024/04/Sanguine-Verif.i-Option-3-300x136.jpg 300w" sizes="(max-width: 741px) 100vw, 741px" />

Sanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.com’s Supplier Pre-assessment Program. Onsite, physical lab…

Sanguine Adds Advanced Health Data Integration Capabilities that Further Enhance Translational Medical Research

By mbalanadu | January 10, 2024 |

Sanguine Adds Advanced Health Data Integration Capabilities

<img width="741" height="337" src="https://sanguinebio.com/wp-content/uploads/2024/01/Sanguine-Adds-Advanced-Health-Data-Integration-Capabilities-Option-3.jpg" class="attachment-large size-large wp-post-image" alt="Sanguine Adds Advanced Health Data Integration Capabilities" aria-label="Sanguine Adds Advanced Health Data Integration Capabilities that Further Enhance Translational Medical Research" decoding="async" srcset="https://sanguinebio.com/wp-content/uploads/2024/01/Sanguine-Adds-Advanced-Health-Data-Integration-Capabilities-Option-3.jpg 741w, https://sanguinebio.com/wp-content/uploads/2024/01/Sanguine-Adds-Advanced-Health-Data-Integration-Capabilities-Option-3-300x136.jpg 300w" sizes="(max-width: 741px) 100vw, 741px" />

Comprehensive and real-time electronic health records shorten study timelines and offer new product opportunities

Sanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth

By anadeem | November 1, 2023 |

<img width="741" height="337" src="https://sanguinebio.com/wp-content/uploads/2023/11/Capital-Infusion-Fast-Tracks-Sanguines-Growth-Option-2.jpg" class="attachment-large size-large wp-post-image" alt="" aria-label="Sanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth" decoding="async" srcset="https://sanguinebio.com/wp-content/uploads/2023/11/Capital-Infusion-Fast-Tracks-Sanguines-Growth-Option-2.jpg 741w, https://sanguinebio.com/wp-content/uploads/2023/11/Capital-Infusion-Fast-Tracks-Sanguines-Growth-Option-2-300x136.jpg 300w" sizes="(max-width: 741px) 100vw, 741px" />

Capital infusion fast-tracks the development of apheresis-derived products critical to cell and gene therapy research and manufacturing.

Sanguine Biosciences Opens New Apheresis Donor Center in Los Angeles

By anadeem | September 26, 2023 |

<img width="1024" height="684" src="https://sanguinebio.com/wp-content/uploads/2023/09/LA-times-news-1024x684.png" class="attachment-large size-large wp-post-image" alt="" aria-label="Sanguine Biosciences Opens New Apheresis Donor Center in Los Angeles" decoding="async" srcset="https://sanguinebio.com/wp-content/uploads/2023/09/LA-times-news-1024x684.png 1024w, https://sanguinebio.com/wp-content/uploads/2023/09/LA-times-news-300x200.png 300w, https://sanguinebio.com/wp-content/uploads/2023/09/LA-times-news-768x513.png 768w, https://sanguinebio.com/wp-content/uploads/2023/09/LA-times-news-1140x761.png 1140w, https://sanguinebio.com/wp-content/uploads/2023/09/LA-times-news-740x494.png 740w, https://sanguinebio.com/wp-content/uploads/2023/09/LA-times-news.png 1200w" sizes="(max-width: 1024px) 100vw, 1024px" />

Sangine will collect concentrated white blood cell biospecimens through apheresis from participants in Sanguine’s Southern California Patient Community…

Sanguine Opens New Apheresis Donor Center to Support Cell & Gene Therapy and Translational Research Initiatives

By anadeem | September 13, 2023 |

<img width="1024" height="519" src="https://sanguinebio.com/wp-content/uploads/2023/09/blue-bkg-press-1024x519.png" class="attachment-large size-large wp-post-image" alt="" aria-label="Sanguine Opens New Apheresis Donor Center to Support Cell & Gene Therapy and Translational Research Initiatives" decoding="async" srcset="https://sanguinebio.com/wp-content/uploads/2023/09/blue-bkg-press-1024x519.png 1024w, https://sanguinebio.com/wp-content/uploads/2023/09/blue-bkg-press-300x152.png 300w, https://sanguinebio.com/wp-content/uploads/2023/09/blue-bkg-press-768x390.png 768w, https://sanguinebio.com/wp-content/uploads/2023/09/blue-bkg-press-1140x578.png 1140w, https://sanguinebio.com/wp-content/uploads/2023/09/blue-bkg-press-740x375.png 740w, https://sanguinebio.com/wp-content/uploads/2023/09/blue-bkg-press.png 1530w" sizes="(max-width: 1024px) 100vw, 1024px" />

The facility in the heart of Los Angeles enables the delivery of the highest quality and most relevant…

Sanguine Biosciences Partners with Broadoak Capital Partners to Accelerate Launch of New Products and Services In Support of Cell & Gene Therapy Markets

By Lisa Scimemi | January 9, 2023 |

<img width="741" height="441" src="https://sanguinebio.com/wp-content/uploads/2023/01/Sanguine-Partners-with-Broadoak-Capital-Partners-Website.jpg" class="attachment-large size-large wp-post-image" alt="" aria-label="Sanguine Biosciences Partners with Broadoak Capital Partners to Accelerate Launch of New Products and Services In Support of Cell & Gene Therapy Markets" decoding="async" srcset="https://sanguinebio.com/wp-content/uploads/2023/01/Sanguine-Partners-with-Broadoak-Capital-Partners-Website.jpg 741w, https://sanguinebio.com/wp-content/uploads/2023/01/Sanguine-Partners-with-Broadoak-Capital-Partners-Website-300x179.jpg 300w" sizes="(max-width: 741px) 100vw, 741px" />

Investment will support ongoing partnerships with apheresis clinics, expansion of laboratory services, enhancement of patient data aggregation, and…

Fortune Best Small Workplaces – #30 out of 100 in the US

By Shahana Khan | August 11, 2022 |

<img width="741" height="441" src="https://sanguinebio.com/wp-content/uploads/2022/08/Building-on-the-Power-of-Purpose-Web-banner.jpg" class="attachment-large size-large wp-post-image" alt="" aria-label="Fortune Best Small Workplaces – #30 out of 100 in the US" decoding="async" srcset="https://sanguinebio.com/wp-content/uploads/2022/08/Building-on-the-Power-of-Purpose-Web-banner.jpg 741w, https://sanguinebio.com/wp-content/uploads/2022/08/Building-on-the-Power-of-Purpose-Web-banner-300x179.jpg 300w" sizes="(max-width: 741px) 100vw, 741px" />

Building on the Power of Purpose Sanguine Biosciences leverages employee feedback to ensure workers feel heard and are…

PODCAST: The Bio Report: Bringing the Trial to the Patient

By Sanguine | April 16, 2021

<img width="740" height="400" src="https://sanguinebio.com/wp-content/uploads/2021/04/Bio-Report-Podcast-Thumbnail-1st-Option.jpg" class="attachment-large size-large wp-post-image" alt="" aria-label="PODCAST: The Bio Report: Bringing the Trial to the Patient" decoding="async" srcset="https://sanguinebio.com/wp-content/uploads/2021/04/Bio-Report-Podcast-Thumbnail-1st-Option.jpg 740w, https://sanguinebio.com/wp-content/uploads/2021/04/Bio-Report-Podcast-Thumbnail-1st-Option-300x162.jpg 300w, https://sanguinebio.com/wp-content/uploads/2021/04/Bio-Report-Podcast-Thumbnail-1st-Option-500x270.jpg 500w, https://sanguinebio.com/wp-content/uploads/2021/04/Bio-Report-Podcast-Thumbnail-1st-Option-370x200.jpg 370w" sizes="(max-width: 740px) 100vw, 740px" />

One of the challenges to securing the participation of patients in clinical trials can be simple geography. Sanguine…